Recombinant Human Erythropoietin (Rhepo) in Clinical Oncology - M. R. Nowrousian | Consegna Gratis
Test ammissione Medicina, Odontoiatria, Professioni sanitarie Tutti i libri per la preparazione al test

Recombinant Human Erythropoietin (Rhepo) in Clinical Oncology

Recombinant Human Erythropoietin (Rhepo) in Clinical Oncology
titolo Recombinant Human Erythropoietin (Rhepo) in Clinical Oncology
sottotitolo Scientific and Clinical Aspects of Anemia in Cancer
argomenti Medicina Ematologia Anemie
Medicina Oncologia Ematoncologia
Medicina Ematologia
Medicina Oncologia
formato Libro
pagine 511
pubblicazione 2003
ISBN 9783211836613
18app Carta del docente Acquistabile con bonus 18app o Carta del docente
112,00 106,40 (-5%)
Disponibilità immediata
Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented and future developments are discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO. The book will serve as an authentic and essential source of information for radiotherapists, oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion or laboratory medicine and pharmacologists.

Indice testuale

Biology of EPO * Definition and classification of anemia * Pathogenesis of cancer-related or chemotherapy-induced anemia * Prevalence and prognostic role of anemia in cancer chemotherapy * Incidence and impact of anemia in radiation oncology * Relatioship between anemia and tumor hypoxia * Tumor hypoxia and therapeutic resistance * Impact of anemia on organ functions * Relationship between anemia, fatigue, and quality of life in cancer patients * Red blood cell transfusions, risks and limitations * Pharmacology, pharmacokinetics and safty of rhEPO * rhEPO in anemia associated with multiple myeloma and non-Hodgkin lymphoma * rhEPO in myelodysplastic syndromes and chronic myeloproliferative diseases * rhEPO in anemia associated with solid tumors and chemotherapy * Predictive factors for response of anemia to rhEPO * rhEPO in hematopoietic stem cell mobilization, transplatation, and in-vitro expansion * Clinical trails using rhEPO in radiation oncology * rhEPO in pediatric oncology * rhEPO in surgical oncology.

Ti potrebbe interessare anche

Inserire il codice per il download.

Inserire il codice per attivare il servizio.

Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy.
Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy.
Chiudendo questo avviso, navigando in questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all'uso dei cookie.